Insights

Strategic partnership Hager Biosciences is a preclinical-stage drug discovery outfit with a focus on medicinal chemistry and FragPhore platform for rapid lead generation. This suggests sales opportunities in out-licensing collaborations, joint discovery programs, or milestone-based partnerships with pharma/biotech firms seeking early-stage optimization for CNS targets.

CNS focus With a track record of CNS-related preclinical candidates and patents, target customer conversations should emphasize neurological disease programs, potential for early engagement in GABA A discovery efforts, and collaboration around therapeutic leads for Alzheimer’s and other CNS disorders.

IP and exclusivity Existing and emerging IP around FragPhore derived compounds positions Hager as a potential partner for exclusive out-licensing or co-development agreements, enabling buyers to strengthen their IP estates while accelerating candidate optimization.

Unlock early value Small-scale, cost-effective discovery services combined with outsourced infrastructure suggest opportunities to offer project-based engagements, CRO-like discovery sprints, or milestone-driven collaborations that minimize upfront spend for pharmaceutical customers.

Strategic partnerships history A proven collaboration with AgeneBio highlights a receptiveness to partner ecosystems; leverage this track record to approach additional neurodegenerative and CNS players looking for specialized medicinal chemistry capabilities and rapid lead provisioning.

Similar companies to Hager Biosciences, LLC

Hager Biosciences, LLC Tech Stack

Hager Biosciences, LLC uses 8 technology products and services including Glide.js, jQuery, HSTS, and more. Explore Hager Biosciences, LLC's tech stack below.

  • Glide.js
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • HSTS
    Security
  • Video Players
  • Microsoft ASP.NET
    Web Frameworks
  • Microsoft IIS
    Web Servers
  • Nginx
    Web Servers
  • OpenResty
    Web Servers

Hager Biosciences, LLC's Email Address Formats

Hager Biosciences, LLC uses at least 2 email formats:
Hager Biosciences, LLC Email FormatsExamplePercentage
FLast@hagerbio.comJDoe@hagerbio.com
67%
First.Last@hagerbio.comJohn.Doe@hagerbio.com
33%

Frequently Asked Questions

What is Hager Biosciences, LLC's official website and social media links?

Minus sign iconPlus sign icon
Hager Biosciences, LLC's official website is hagerbio.com and has social profiles on LinkedIn.

How much revenue does Hager Biosciences, LLC generate?

Minus sign iconPlus sign icon
As of September 2026, Hager Biosciences, LLC's annual revenue is estimated to be $1M - $10M.

What is Hager Biosciences, LLC's SIC code and NAICS code?

Minus sign iconPlus sign icon
Hager Biosciences, LLC's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Hager Biosciences, LLC have currently?

Minus sign iconPlus sign icon
As of September 2026, Hager Biosciences, LLC has approximately 7 employees across 1 continents, including North America. Key team members include Chief Scientific Officer & Senior Vice President Of Research: J. B., Head Of Chemistry: J. H. and Founder, President & Ceo: B. M. Explore Hager Biosciences, LLC's employee directory with LeadIQ.

What industry does Hager Biosciences, LLC belong to?

Minus sign iconPlus sign icon
Hager Biosciences, LLC operates in the Biotechnology Research industry.

What technology does Hager Biosciences, LLC use?

Minus sign iconPlus sign icon
Hager Biosciences, LLC's tech stack includes Glide.js, jQuery, HSTS, Vimeo, Microsoft ASP.NET, Microsoft IIS, Nginx and OpenResty.

What is Hager Biosciences, LLC's email format?

Minus sign iconPlus sign icon
Hager Biosciences, LLC's email format typically follows the pattern of FLast@hagerbio.com. Find more Hager Biosciences, LLC email formats with LeadIQ.
Hager Biosciences, LLC logo

Hager Biosciences, LLC

Biotechnology ResearchPennsylvania, United States2-10 Employees

Hager Biosciences, LLC is a small biotechnology research firm based in Bethlehem, Pennsylvania, focused on preclinical drug discovery. It specializes in medicinal chemistry, designing and synthesizing proprietary fragment-based molecules for use in optimizing existing candidates or creating novel drug candidates. The company aims to be a preferred partner to pharmaceutical and biotech firms by providing therapeutic leads through out-licensing to address unmet medical needs.

Its discovery process emphasizes cost efficiency and relies on an outsourced network to speed lead generation and optimization. Hager Biosciences has demonstrated an intellectual property track record in CNS-focused preclinical work, including multiple patents and applications and two Alzheimer's-related candidates approaching human trials.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
2-10

Section iconFunding & Financials

  • $1M - $10M

    Hager Biosciences, LLC's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.